The ENHANCE trial is a randomized study aimed at studying the effect of ezetimibe on top of simvastatin versus simvastatin on carotid intima–media thickness in 720 patients with heterozygous ...

BOSTON, March 24, 2025 /PRNewswire/ -- PhaseV, a leader in AI/ML-driven clinical development, announced today that it will ...

The final analysis showed similar overall survival, progression-free survival, and objective response rates, with no new safety signals identified compared with the primary analysis.

In conclusion, in the ENHANCE trial, ezetimibe in addition to simvastatin did not produce reduction in carotid IMT despite achieving a significant differential reduction in LDL-C. Although these ...